nodes	percent_of_prediction	percent_of_DWPC	metapath
Baclofen—SLC22A8—nephron—kidney cancer	0.0284	0.286	CbGeAlD
Baclofen—SLC22A8—urine—kidney cancer	0.0228	0.229	CbGeAlD
Baclofen—GABBR1—cortex of kidney—kidney cancer	0.0133	0.134	CbGeAlD
Baclofen—GABBR1—cardiac atrium—kidney cancer	0.0126	0.127	CbGeAlD
Baclofen—SLC22A8—nephron tubule—kidney cancer	0.00613	0.0617	CbGeAlD
Baclofen—SLC22A8—renal system—kidney cancer	0.00557	0.0561	CbGeAlD
Baclofen—SLC22A8—kidney—kidney cancer	0.00539	0.0542	CbGeAlD
Baclofen—SLC22A8—cortex of kidney—kidney cancer	0.00525	0.0528	CbGeAlD
Baclofen—Chlorphenesin—BCHE—kidney cancer	0.00473	0.322	CrCbGaD
Baclofen—Chlorpropamide—PTGS1—kidney cancer	0.00289	0.196	CrCbGaD
Baclofen—Chlorphenesin—PTGS2—kidney cancer	0.00218	0.148	CrCbGaD
Baclofen—GABBR2—Potassium Channels—KCNMA1—kidney cancer	0.00212	0.0594	CbGpPWpGaD
Baclofen—Ibuprofen—PTGS1—kidney cancer	0.0017	0.116	CrCbGaD
Baclofen—Chlorpropamide—ABCB1—kidney cancer	0.0014	0.0955	CrCbGaD
Baclofen—GABBR1—Potassium Channels—KCNMA1—kidney cancer	0.00137	0.0383	CbGpPWpGaD
Baclofen—Ibuprofen—PTGS2—kidney cancer	0.000973	0.0662	CrCbGaD
Baclofen—GABBR2—Neuronal System—KCNMA1—kidney cancer	0.000927	0.0259	CbGpPWpGaD
Baclofen—GABBR2—Transmission across Chemical Synapses—ACHE—kidney cancer	0.000895	0.025	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—OR4C13—kidney cancer	0.000836	0.0234	CbGpPWpGaD
Baclofen—Ibuprofen—ABCB1—kidney cancer	0.000827	0.0563	CrCbGaD
Baclofen—GABBR2—Transmission across Chemical Synapses—BCHE—kidney cancer	0.00078	0.0218	CbGpPWpGaD
Baclofen—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A3—kidney cancer	0.000771	0.0216	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—OR4C13—kidney cancer	0.000759	0.0212	CbGpPWpGaD
Baclofen—GABBR2—G alpha (i) signalling events—ANXA1—kidney cancer	0.000723	0.0202	CbGpPWpGaD
Baclofen—GABBR2—Neuronal System—ACHE—kidney cancer	0.000686	0.0192	CbGpPWpGaD
Baclofen—GABBR2—Neuronal System—BCHE—kidney cancer	0.000598	0.0167	CbGpPWpGaD
Baclofen—GABBR1—Neuronal System—KCNMA1—kidney cancer	0.000598	0.0167	CbGpPWpGaD
Baclofen—GABBR1—Transmission across Chemical Synapses—ACHE—kidney cancer	0.000577	0.0161	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—OR4C13—kidney cancer	0.000539	0.0151	CbGpPWpGaD
Baclofen—GABBR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—kidney cancer	0.000529	0.0148	CbGpPWpGaD
Baclofen—GABBR1—Transmission across Chemical Synapses—BCHE—kidney cancer	0.000503	0.0141	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—OR4C13—kidney cancer	0.000489	0.0137	CbGpPWpGaD
Baclofen—GABBR1—G alpha (i) signalling events—ANXA1—kidney cancer	0.000466	0.013	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—OR4C13—kidney cancer	0.000449	0.0125	CbGpPWpGaD
Baclofen—GABBR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—kidney cancer	0.000442	0.0124	CbGpPWpGaD
Baclofen—GABBR1—Neuronal System—ACHE—kidney cancer	0.000442	0.0124	CbGpPWpGaD
Baclofen—GABBR2—GPCR ligand binding—ANXA1—kidney cancer	0.000438	0.0122	CbGpPWpGaD
Baclofen—Dyspnoea—Gemcitabine—kidney cancer	0.000409	0.000482	CcSEcCtD
Baclofen—Nausea—Vinblastine—kidney cancer	0.000409	0.000481	CcSEcCtD
Baclofen—Somnolence—Gemcitabine—kidney cancer	0.000408	0.00048	CcSEcCtD
Baclofen—Convulsion—Paclitaxel—kidney cancer	0.000408	0.00048	CcSEcCtD
Baclofen—Affect lability—Doxorubicin—kidney cancer	0.000407	0.000479	CcSEcCtD
Baclofen—Nausea—Everolimus—kidney cancer	0.000407	0.000479	CcSEcCtD
Baclofen—Diarrhoea—Sorafenib—kidney cancer	0.000407	0.000479	CcSEcCtD
Baclofen—Hypertension—Paclitaxel—kidney cancer	0.000407	0.000478	CcSEcCtD
Baclofen—Pruritus—Sunitinib—kidney cancer	0.000405	0.000476	CcSEcCtD
Baclofen—Angiopathy—Capecitabine—kidney cancer	0.000403	0.000474	CcSEcCtD
Baclofen—Chest pain—Paclitaxel—kidney cancer	0.000401	0.000472	CcSEcCtD
Baclofen—Myalgia—Paclitaxel—kidney cancer	0.000401	0.000472	CcSEcCtD
Baclofen—Mediastinal disorder—Capecitabine—kidney cancer	0.0004	0.000471	CcSEcCtD
Baclofen—Anxiety—Paclitaxel—kidney cancer	0.0004	0.00047	CcSEcCtD
Baclofen—Face oedema—Doxorubicin—kidney cancer	0.0004	0.00047	CcSEcCtD
Baclofen—Decreased appetite—Gemcitabine—kidney cancer	0.000399	0.00047	CcSEcCtD
Baclofen—Chills—Capecitabine—kidney cancer	0.000399	0.000469	CcSEcCtD
Baclofen—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000398	0.000469	CcSEcCtD
Baclofen—GABBR2—Transmission across Chemical Synapses—BRAF—kidney cancer	0.000398	0.0111	CbGpPWpGaD
Baclofen—Arrhythmia—Capecitabine—kidney cancer	0.000397	0.000467	CcSEcCtD
Baclofen—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000396	0.000466	CcSEcCtD
Baclofen—Discomfort—Paclitaxel—kidney cancer	0.000396	0.000466	CcSEcCtD
Baclofen—Fatigue—Gemcitabine—kidney cancer	0.000396	0.000466	CcSEcCtD
Baclofen—Gastrointestinal pain—Vincristine—kidney cancer	0.000396	0.000466	CcSEcCtD
Baclofen—Dizziness—Sorafenib—kidney cancer	0.000393	0.000463	CcSEcCtD
Baclofen—Constipation—Gemcitabine—kidney cancer	0.000393	0.000462	CcSEcCtD
Baclofen—Pain—Gemcitabine—kidney cancer	0.000393	0.000462	CcSEcCtD
Baclofen—Nausea—Erlotinib—kidney cancer	0.000393	0.000462	CcSEcCtD
Baclofen—Alopecia—Capecitabine—kidney cancer	0.000392	0.000462	CcSEcCtD
Baclofen—Dry mouth—Paclitaxel—kidney cancer	0.000392	0.000461	CcSEcCtD
Baclofen—Mood swings—Doxorubicin—kidney cancer	0.000392	0.000461	CcSEcCtD
Baclofen—Diarrhoea—Sunitinib—kidney cancer	0.000392	0.000461	CcSEcCtD
Baclofen—Ataxia—Doxorubicin—kidney cancer	0.000389	0.000458	CcSEcCtD
Baclofen—Mental disorder—Capecitabine—kidney cancer	0.000389	0.000458	CcSEcCtD
Baclofen—Asthenia—Dactinomycin—kidney cancer	0.000389	0.000457	CcSEcCtD
Baclofen—Confusional state—Paclitaxel—kidney cancer	0.000388	0.000456	CcSEcCtD
Baclofen—Malnutrition—Capecitabine—kidney cancer	0.000387	0.000455	CcSEcCtD
Baclofen—GABBR1—Neuronal System—BCHE—kidney cancer	0.000385	0.0108	CbGpPWpGaD
Baclofen—Dehydration—Doxorubicin—kidney cancer	0.000385	0.000453	CcSEcCtD
Baclofen—Oedema—Paclitaxel—kidney cancer	0.000385	0.000452	CcSEcCtD
Baclofen—Abdominal pain—Vincristine—kidney cancer	0.000383	0.00045	CcSEcCtD
Baclofen—Body temperature increased—Vincristine—kidney cancer	0.000383	0.00045	CcSEcCtD
Baclofen—Infection—Paclitaxel—kidney cancer	0.000382	0.000449	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—LATS1—kidney cancer	0.000381	0.0107	CbGpPWpGaD
Baclofen—Flatulence—Capecitabine—kidney cancer	0.000381	0.000448	CcSEcCtD
Baclofen—Dysgeusia—Capecitabine—kidney cancer	0.000379	0.000445	CcSEcCtD
Baclofen—Dizziness—Sunitinib—kidney cancer	0.000378	0.000445	CcSEcCtD
Baclofen—Feeling abnormal—Gemcitabine—kidney cancer	0.000378	0.000445	CcSEcCtD
Baclofen—Shock—Paclitaxel—kidney cancer	0.000378	0.000445	CcSEcCtD
Baclofen—Vomiting—Sorafenib—kidney cancer	0.000378	0.000445	CcSEcCtD
Baclofen—Orthostatic hypotension—Doxorubicin—kidney cancer	0.000378	0.000445	CcSEcCtD
Baclofen—Nervous system disorder—Paclitaxel—kidney cancer	0.000377	0.000444	CcSEcCtD
Baclofen—Tachycardia—Paclitaxel—kidney cancer	0.000375	0.000441	CcSEcCtD
Baclofen—Rash—Sorafenib—kidney cancer	0.000375	0.000441	CcSEcCtD
Baclofen—Dermatitis—Sorafenib—kidney cancer	0.000375	0.000441	CcSEcCtD
Baclofen—Back pain—Capecitabine—kidney cancer	0.000374	0.00044	CcSEcCtD
Baclofen—Breast disorder—Doxorubicin—kidney cancer	0.000374	0.00044	CcSEcCtD
Baclofen—Skin disorder—Paclitaxel—kidney cancer	0.000373	0.000439	CcSEcCtD
Baclofen—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	0.000373	0.000438	CcSEcCtD
Baclofen—Headache—Sorafenib—kidney cancer	0.000373	0.000438	CcSEcCtD
Baclofen—Hyperhidrosis—Paclitaxel—kidney cancer	0.000372	0.000437	CcSEcCtD
Baclofen—Diarrhoea—Dactinomycin—kidney cancer	0.000371	0.000436	CcSEcCtD
Baclofen—Anorexia—Paclitaxel—kidney cancer	0.000367	0.000431	CcSEcCtD
Baclofen—Muscular weakness—Doxorubicin—kidney cancer	0.000365	0.000429	CcSEcCtD
Baclofen—Vision blurred—Capecitabine—kidney cancer	0.000364	0.000429	CcSEcCtD
Baclofen—Vomiting—Sunitinib—kidney cancer	0.000364	0.000428	CcSEcCtD
Baclofen—Body temperature increased—Gemcitabine—kidney cancer	0.000363	0.000427	CcSEcCtD
Baclofen—Tremor—Capecitabine—kidney cancer	0.000362	0.000426	CcSEcCtD
Baclofen—Rash—Sunitinib—kidney cancer	0.000361	0.000424	CcSEcCtD
Baclofen—Dermatitis—Sunitinib—kidney cancer	0.000361	0.000424	CcSEcCtD
Baclofen—Hypotension—Paclitaxel—kidney cancer	0.000359	0.000423	CcSEcCtD
Baclofen—Ill-defined disorder—Capecitabine—kidney cancer	0.000359	0.000422	CcSEcCtD
Baclofen—Headache—Sunitinib—kidney cancer	0.000359	0.000422	CcSEcCtD
Baclofen—Influenza—Doxorubicin—kidney cancer	0.000358	0.000421	CcSEcCtD
Baclofen—Dysphagia—Doxorubicin—kidney cancer	0.000358	0.000421	CcSEcCtD
Baclofen—Anaemia—Capecitabine—kidney cancer	0.000357	0.00042	CcSEcCtD
Baclofen—GABBR2—G alpha (i) signalling events—POMC—kidney cancer	0.000354	0.00991	CbGpPWpGaD
Baclofen—Nausea—Sorafenib—kidney cancer	0.000353	0.000416	CcSEcCtD
Baclofen—SLC22A8—SLC-mediated transmembrane transport—SLC5A3—kidney cancer	0.00035	0.0098	CbGpPWpGaD
Baclofen—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.00035	0.000412	CcSEcCtD
Baclofen—Malaise—Capecitabine—kidney cancer	0.000349	0.00041	CcSEcCtD
Baclofen—Insomnia—Paclitaxel—kidney cancer	0.000348	0.000409	CcSEcCtD
Baclofen—Vertigo—Capecitabine—kidney cancer	0.000347	0.000409	CcSEcCtD
Baclofen—Asthenia—Vincristine—kidney cancer	0.000347	0.000409	CcSEcCtD
Baclofen—GABBR2—GPCR downstream signaling—AKAP13—kidney cancer	0.000347	0.00971	CbGpPWpGaD
Baclofen—Syncope—Capecitabine—kidney cancer	0.000347	0.000408	CcSEcCtD
Baclofen—Paraesthesia—Paclitaxel—kidney cancer	0.000345	0.000406	CcSEcCtD
Baclofen—Vomiting—Dactinomycin—kidney cancer	0.000345	0.000405	CcSEcCtD
Baclofen—Dyspnoea—Paclitaxel—kidney cancer	0.000343	0.000403	CcSEcCtD
Baclofen—Somnolence—Paclitaxel—kidney cancer	0.000342	0.000402	CcSEcCtD
Baclofen—Palpitations—Capecitabine—kidney cancer	0.000342	0.000402	CcSEcCtD
Baclofen—Rash—Dactinomycin—kidney cancer	0.000342	0.000402	CcSEcCtD
Baclofen—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—kidney cancer	0.000341	0.00954	CbGpPWpGaD
Baclofen—Nausea—Sunitinib—kidney cancer	0.00034	0.0004	CcSEcCtD
Baclofen—Loss of consciousness—Capecitabine—kidney cancer	0.00034	0.0004	CcSEcCtD
Baclofen—Dyspepsia—Paclitaxel—kidney cancer	0.000338	0.000398	CcSEcCtD
Baclofen—Dysuria—Doxorubicin—kidney cancer	0.000334	0.000393	CcSEcCtD
Baclofen—Decreased appetite—Paclitaxel—kidney cancer	0.000334	0.000393	CcSEcCtD
Baclofen—Hypertension—Capecitabine—kidney cancer	0.000334	0.000393	CcSEcCtD
Baclofen—GABBR2—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000332	0.0093	CbGpPWpGaD
Baclofen—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000332	0.00039	CcSEcCtD
Baclofen—Fatigue—Paclitaxel—kidney cancer	0.000332	0.00039	CcSEcCtD
Baclofen—Diarrhoea—Vincristine—kidney cancer	0.000331	0.00039	CcSEcCtD
Baclofen—Pollakiuria—Doxorubicin—kidney cancer	0.00033	0.000389	CcSEcCtD
Baclofen—Asthenia—Gemcitabine—kidney cancer	0.00033	0.000388	CcSEcCtD
Baclofen—Chest pain—Capecitabine—kidney cancer	0.000329	0.000387	CcSEcCtD
Baclofen—Myalgia—Capecitabine—kidney cancer	0.000329	0.000387	CcSEcCtD
Baclofen—Constipation—Paclitaxel—kidney cancer	0.000329	0.000387	CcSEcCtD
Baclofen—Pain—Paclitaxel—kidney cancer	0.000329	0.000387	CcSEcCtD
Baclofen—Anxiety—Capecitabine—kidney cancer	0.000328	0.000386	CcSEcCtD
Baclofen—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000327	0.000385	CcSEcCtD
Baclofen—Weight increased—Doxorubicin—kidney cancer	0.000326	0.000383	CcSEcCtD
Baclofen—Discomfort—Capecitabine—kidney cancer	0.000325	0.000383	CcSEcCtD
Baclofen—Pruritus—Gemcitabine—kidney cancer	0.000325	0.000382	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—AMER1—kidney cancer	0.000324	0.00907	CbGpPWpGaD
Baclofen—Weight decreased—Doxorubicin—kidney cancer	0.000324	0.000381	CcSEcCtD
Baclofen—Hyperglycaemia—Doxorubicin—kidney cancer	0.000323	0.00038	CcSEcCtD
Baclofen—Dry mouth—Capecitabine—kidney cancer	0.000322	0.000379	CcSEcCtD
Baclofen—Nausea—Dactinomycin—kidney cancer	0.000322	0.000379	CcSEcCtD
Baclofen—Pneumonia—Doxorubicin—kidney cancer	0.000321	0.000377	CcSEcCtD
Baclofen—Dizziness—Vincristine—kidney cancer	0.00032	0.000377	CcSEcCtD
Baclofen—Drowsiness—Doxorubicin—kidney cancer	0.000319	0.000375	CcSEcCtD
Baclofen—Confusional state—Capecitabine—kidney cancer	0.000318	0.000374	CcSEcCtD
Baclofen—Feeling abnormal—Paclitaxel—kidney cancer	0.000317	0.000373	CcSEcCtD
Baclofen—Oedema—Capecitabine—kidney cancer	0.000316	0.000371	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—AKAP13—kidney cancer	0.000315	0.00882	CbGpPWpGaD
Baclofen—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000314	0.00037	CcSEcCtD
Baclofen—Diarrhoea—Gemcitabine—kidney cancer	0.000314	0.00037	CcSEcCtD
Baclofen—Renal failure—Doxorubicin—kidney cancer	0.000313	0.000369	CcSEcCtD
Baclofen—Infection—Capecitabine—kidney cancer	0.000313	0.000369	CcSEcCtD
Baclofen—Shock—Capecitabine—kidney cancer	0.00031	0.000365	CcSEcCtD
Baclofen—SLC22A8—Transmembrane transport of small molecules—RYR1—kidney cancer	0.00031	0.00867	CbGpPWpGaD
Baclofen—Nervous system disorder—Capecitabine—kidney cancer	0.000309	0.000364	CcSEcCtD
Baclofen—Tachycardia—Capecitabine—kidney cancer	0.000308	0.000362	CcSEcCtD
Baclofen—Vomiting—Vincristine—kidney cancer	0.000308	0.000362	CcSEcCtD
Baclofen—Skin disorder—Capecitabine—kidney cancer	0.000306	0.000361	CcSEcCtD
Baclofen—Sweating—Doxorubicin—kidney cancer	0.000306	0.00036	CcSEcCtD
Baclofen—Urticaria—Paclitaxel—kidney cancer	0.000305	0.000359	CcSEcCtD
Baclofen—Rash—Vincristine—kidney cancer	0.000305	0.000359	CcSEcCtD
Baclofen—Hyperhidrosis—Capecitabine—kidney cancer	0.000305	0.000359	CcSEcCtD
Baclofen—GABBR2—Neuronal System—BRAF—kidney cancer	0.000305	0.00853	CbGpPWpGaD
Baclofen—Dermatitis—Vincristine—kidney cancer	0.000305	0.000359	CcSEcCtD
Baclofen—Haematuria—Doxorubicin—kidney cancer	0.000304	0.000358	CcSEcCtD
Baclofen—Body temperature increased—Paclitaxel—kidney cancer	0.000304	0.000358	CcSEcCtD
Baclofen—Abdominal pain—Paclitaxel—kidney cancer	0.000304	0.000358	CcSEcCtD
Baclofen—Headache—Vincristine—kidney cancer	0.000303	0.000357	CcSEcCtD
Baclofen—GABBR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	0.000303	0.00848	CbGpPWpGaD
Baclofen—Hepatobiliary disease—Doxorubicin—kidney cancer	0.000302	0.000355	CcSEcCtD
Baclofen—Anorexia—Capecitabine—kidney cancer	0.000301	0.000354	CcSEcCtD
Baclofen—GABBR2—GPCR downstream signaling—ITPR2—kidney cancer	0.000295	0.00826	CbGpPWpGaD
Baclofen—Hypotension—Capecitabine—kidney cancer	0.000295	0.000347	CcSEcCtD
Baclofen—Vomiting—Gemcitabine—kidney cancer	0.000292	0.000343	CcSEcCtD
Baclofen—Bradycardia—Doxorubicin—kidney cancer	0.000291	0.000343	CcSEcCtD
Baclofen—Rash—Gemcitabine—kidney cancer	0.00029	0.000341	CcSEcCtD
Baclofen—Dermatitis—Gemcitabine—kidney cancer	0.000289	0.00034	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—OR4C13—kidney cancer	0.000289	0.00809	CbGpPWpGaD
Baclofen—Headache—Gemcitabine—kidney cancer	0.000288	0.000338	CcSEcCtD
Baclofen—Nausea—Vincristine—kidney cancer	0.000288	0.000338	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000287	0.000338	CcSEcCtD
Baclofen—Rhinitis—Doxorubicin—kidney cancer	0.000287	0.000338	CcSEcCtD
Baclofen—Insomnia—Capecitabine—kidney cancer	0.000285	0.000336	CcSEcCtD
Baclofen—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—kidney cancer	0.000285	0.00797	CbGpPWpGaD
Baclofen—Hypoaesthesia—Doxorubicin—kidney cancer	0.000285	0.000335	CcSEcCtD
Baclofen—Paraesthesia—Capecitabine—kidney cancer	0.000283	0.000333	CcSEcCtD
Baclofen—Urinary tract disorder—Doxorubicin—kidney cancer	0.000283	0.000333	CcSEcCtD
Baclofen—GABBR1—GPCR ligand binding—ANXA1—kidney cancer	0.000282	0.00789	CbGpPWpGaD
Baclofen—Oedema peripheral—Doxorubicin—kidney cancer	0.000282	0.000332	CcSEcCtD
Baclofen—Connective tissue disorder—Doxorubicin—kidney cancer	0.000281	0.000331	CcSEcCtD
Baclofen—Dyspnoea—Capecitabine—kidney cancer	0.000281	0.000331	CcSEcCtD
Baclofen—Urethral disorder—Doxorubicin—kidney cancer	0.000281	0.00033	CcSEcCtD
Baclofen—Dyspepsia—Capecitabine—kidney cancer	0.000278	0.000327	CcSEcCtD
Baclofen—Visual impairment—Doxorubicin—kidney cancer	0.000276	0.000325	CcSEcCtD
Baclofen—Asthenia—Paclitaxel—kidney cancer	0.000276	0.000324	CcSEcCtD
Baclofen—Decreased appetite—Capecitabine—kidney cancer	0.000274	0.000323	CcSEcCtD
Baclofen—Nausea—Gemcitabine—kidney cancer	0.000273	0.000321	CcSEcCtD
Baclofen—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000272	0.00032	CcSEcCtD
Baclofen—Fatigue—Capecitabine—kidney cancer	0.000272	0.00032	CcSEcCtD
Baclofen—Pruritus—Paclitaxel—kidney cancer	0.000272	0.00032	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—GPC3—kidney cancer	0.000272	0.0076	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CER1—kidney cancer	0.000272	0.0076	CbGpPWpGaD
Baclofen—Pain—Capecitabine—kidney cancer	0.00027	0.000317	CcSEcCtD
Baclofen—Constipation—Capecitabine—kidney cancer	0.00027	0.000317	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—ITPR2—kidney cancer	0.000268	0.0075	CbGpPWpGaD
Baclofen—Eye disorder—Doxorubicin—kidney cancer	0.000268	0.000315	CcSEcCtD
Baclofen—Tinnitus—Doxorubicin—kidney cancer	0.000267	0.000314	CcSEcCtD
Baclofen—Flushing—Doxorubicin—kidney cancer	0.000266	0.000313	CcSEcCtD
Baclofen—Cardiac disorder—Doxorubicin—kidney cancer	0.000266	0.000313	CcSEcCtD
Baclofen—Diarrhoea—Paclitaxel—kidney cancer	0.000263	0.000309	CcSEcCtD
Baclofen—Feeling abnormal—Capecitabine—kidney cancer	0.00026	0.000306	CcSEcCtD
Baclofen—Angiopathy—Doxorubicin—kidney cancer	0.00026	0.000306	CcSEcCtD
Baclofen—Gastrointestinal pain—Capecitabine—kidney cancer	0.000258	0.000304	CcSEcCtD
Baclofen—Mediastinal disorder—Doxorubicin—kidney cancer	0.000258	0.000303	CcSEcCtD
Baclofen—Chills—Doxorubicin—kidney cancer	0.000257	0.000302	CcSEcCtD
Baclofen—GABBR1—Transmission across Chemical Synapses—BRAF—kidney cancer	0.000256	0.00717	CbGpPWpGaD
Baclofen—Arrhythmia—Doxorubicin—kidney cancer	0.000256	0.000301	CcSEcCtD
Baclofen—GABBR2—Neuronal System—RAF1—kidney cancer	0.000255	0.00712	CbGpPWpGaD
Baclofen—Dizziness—Paclitaxel—kidney cancer	0.000254	0.000299	CcSEcCtD
Baclofen—Alopecia—Doxorubicin—kidney cancer	0.000253	0.000298	CcSEcCtD
Baclofen—Mental disorder—Doxorubicin—kidney cancer	0.000251	0.000295	CcSEcCtD
Baclofen—Urticaria—Capecitabine—kidney cancer	0.000251	0.000295	CcSEcCtD
Baclofen—Abdominal pain—Capecitabine—kidney cancer	0.000249	0.000293	CcSEcCtD
Baclofen—Body temperature increased—Capecitabine—kidney cancer	0.000249	0.000293	CcSEcCtD
Baclofen—Malnutrition—Doxorubicin—kidney cancer	0.000249	0.000293	CcSEcCtD
Baclofen—GABBR2—GPCR downstream signaling—ANXA1—kidney cancer	0.000247	0.00692	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—LATS1—kidney cancer	0.000246	0.00687	CbGpPWpGaD
Baclofen—Flatulence—Doxorubicin—kidney cancer	0.000246	0.000289	CcSEcCtD
Baclofen—Vomiting—Paclitaxel—kidney cancer	0.000244	0.000288	CcSEcCtD
Baclofen—Dysgeusia—Doxorubicin—kidney cancer	0.000244	0.000287	CcSEcCtD
Baclofen—Rash—Paclitaxel—kidney cancer	0.000242	0.000285	CcSEcCtD
Baclofen—Dermatitis—Paclitaxel—kidney cancer	0.000242	0.000285	CcSEcCtD
Baclofen—Back pain—Doxorubicin—kidney cancer	0.000241	0.000284	CcSEcCtD
Baclofen—Headache—Paclitaxel—kidney cancer	0.000241	0.000283	CcSEcCtD
Baclofen—Vision blurred—Doxorubicin—kidney cancer	0.000235	0.000276	CcSEcCtD
Baclofen—Ill-defined disorder—Doxorubicin—kidney cancer	0.000231	0.000272	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—SFRP2—kidney cancer	0.000231	0.00646	CbGpPWpGaD
Baclofen—Anaemia—Doxorubicin—kidney cancer	0.00023	0.000271	CcSEcCtD
Baclofen—Agitation—Doxorubicin—kidney cancer	0.000229	0.000269	CcSEcCtD
Baclofen—Nausea—Paclitaxel—kidney cancer	0.000228	0.000269	CcSEcCtD
Baclofen—GABBR1—G alpha (i) signalling events—POMC—kidney cancer	0.000228	0.00639	CbGpPWpGaD
Baclofen—GABBR2—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000228	0.00638	CbGpPWpGaD
Baclofen—Asthenia—Capecitabine—kidney cancer	0.000226	0.000266	CcSEcCtD
Baclofen—Malaise—Doxorubicin—kidney cancer	0.000225	0.000264	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—ANXA1—kidney cancer	0.000225	0.00628	CbGpPWpGaD
Baclofen—Vertigo—Doxorubicin—kidney cancer	0.000224	0.000263	CcSEcCtD
Baclofen—GABBR1—GPCR downstream signaling—AKAP13—kidney cancer	0.000224	0.00626	CbGpPWpGaD
Baclofen—Syncope—Doxorubicin—kidney cancer	0.000223	0.000263	CcSEcCtD
Baclofen—Pruritus—Capecitabine—kidney cancer	0.000223	0.000263	CcSEcCtD
Baclofen—Palpitations—Doxorubicin—kidney cancer	0.00022	0.000259	CcSEcCtD
Baclofen—Loss of consciousness—Doxorubicin—kidney cancer	0.000219	0.000258	CcSEcCtD
Baclofen—Convulsion—Doxorubicin—kidney cancer	0.000216	0.000254	CcSEcCtD
Baclofen—Diarrhoea—Capecitabine—kidney cancer	0.000216	0.000254	CcSEcCtD
Baclofen—Hypertension—Doxorubicin—kidney cancer	0.000215	0.000253	CcSEcCtD
Baclofen—GABBR2—GPCR ligand binding—POMC—kidney cancer	0.000215	0.006	CbGpPWpGaD
Baclofen—GABBR1—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000214	0.00599	CbGpPWpGaD
Baclofen—Myalgia—Doxorubicin—kidney cancer	0.000212	0.00025	CcSEcCtD
Baclofen—Chest pain—Doxorubicin—kidney cancer	0.000212	0.00025	CcSEcCtD
Baclofen—Anxiety—Doxorubicin—kidney cancer	0.000211	0.000249	CcSEcCtD
Baclofen—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000211	0.000248	CcSEcCtD
Baclofen—Discomfort—Doxorubicin—kidney cancer	0.00021	0.000247	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—AMER1—kidney cancer	0.000209	0.00585	CbGpPWpGaD
Baclofen—Dizziness—Capecitabine—kidney cancer	0.000209	0.000245	CcSEcCtD
Baclofen—Dry mouth—Doxorubicin—kidney cancer	0.000208	0.000244	CcSEcCtD
Baclofen—Confusional state—Doxorubicin—kidney cancer	0.000205	0.000241	CcSEcCtD
Baclofen—Oedema—Doxorubicin—kidney cancer	0.000203	0.000239	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—AKAP13—kidney cancer	0.000203	0.00568	CbGpPWpGaD
Baclofen—Infection—Doxorubicin—kidney cancer	0.000202	0.000238	CcSEcCtD
Baclofen—Vomiting—Capecitabine—kidney cancer	0.000201	0.000236	CcSEcCtD
Baclofen—Shock—Doxorubicin—kidney cancer	0.0002	0.000235	CcSEcCtD
Baclofen—Nervous system disorder—Doxorubicin—kidney cancer	0.000199	0.000235	CcSEcCtD
Baclofen—Rash—Capecitabine—kidney cancer	0.000199	0.000234	CcSEcCtD
Baclofen—Dermatitis—Capecitabine—kidney cancer	0.000199	0.000234	CcSEcCtD
Baclofen—Tachycardia—Doxorubicin—kidney cancer	0.000199	0.000233	CcSEcCtD
Baclofen—Headache—Capecitabine—kidney cancer	0.000198	0.000233	CcSEcCtD
Baclofen—Skin disorder—Doxorubicin—kidney cancer	0.000198	0.000232	CcSEcCtD
Baclofen—Hyperhidrosis—Doxorubicin—kidney cancer	0.000197	0.000231	CcSEcCtD
Baclofen—GABBR1—Neuronal System—BRAF—kidney cancer	0.000197	0.0055	CbGpPWpGaD
Baclofen—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	0.000195	0.00546	CbGpPWpGaD
Baclofen—Anorexia—Doxorubicin—kidney cancer	0.000194	0.000228	CcSEcCtD
Baclofen—GABBR1—GPCR downstream signaling—ITPR2—kidney cancer	0.00019	0.00532	CbGpPWpGaD
Baclofen—Hypotension—Doxorubicin—kidney cancer	0.00019	0.000224	CcSEcCtD
Baclofen—Nausea—Capecitabine—kidney cancer	0.000187	0.00022	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—AKAP13—kidney cancer	0.000186	0.00521	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CASP2—kidney cancer	0.000186	0.00521	CbGpPWpGaD
Baclofen—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000185	0.000218	CcSEcCtD
Baclofen—SLC22A8—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	0.000185	0.00517	CbGpPWpGaD
Baclofen—Insomnia—Doxorubicin—kidney cancer	0.000184	0.000216	CcSEcCtD
Baclofen—Paraesthesia—Doxorubicin—kidney cancer	0.000183	0.000215	CcSEcCtD
Baclofen—Dyspnoea—Doxorubicin—kidney cancer	0.000181	0.000213	CcSEcCtD
Baclofen—Somnolence—Doxorubicin—kidney cancer	0.000181	0.000213	CcSEcCtD
Baclofen—Dyspepsia—Doxorubicin—kidney cancer	0.000179	0.000211	CcSEcCtD
Baclofen—SLC22A8—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	0.000178	0.00499	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.000178	0.00498	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.000178	0.00498	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.000178	0.00498	CbGpPWpGaD
Baclofen—Decreased appetite—Doxorubicin—kidney cancer	0.000177	0.000208	CcSEcCtD
Baclofen—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000176	0.000207	CcSEcCtD
Baclofen—Fatigue—Doxorubicin—kidney cancer	0.000175	0.000206	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—GPC3—kidney cancer	0.000175	0.0049	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CER1—kidney cancer	0.000175	0.0049	CbGpPWpGaD
Baclofen—GABBR2—Neuronal System—MAPK1—kidney cancer	0.000175	0.00488	CbGpPWpGaD
Baclofen—Pain—Doxorubicin—kidney cancer	0.000174	0.000205	CcSEcCtD
Baclofen—Constipation—Doxorubicin—kidney cancer	0.000174	0.000205	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—ITPR2—kidney cancer	0.000173	0.00483	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—GRB7—kidney cancer	0.00017	0.00477	CbGpPWpGaD
Baclofen—Feeling abnormal—Doxorubicin—kidney cancer	0.000168	0.000197	CcSEcCtD
Baclofen—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000166	0.000196	CcSEcCtD
Baclofen—GABBR1—Neuronal System—RAF1—kidney cancer	0.000164	0.00459	CbGpPWpGaD
Baclofen—Urticaria—Doxorubicin—kidney cancer	0.000162	0.00019	CcSEcCtD
Baclofen—Abdominal pain—Doxorubicin—kidney cancer	0.000161	0.000189	CcSEcCtD
Baclofen—Body temperature increased—Doxorubicin—kidney cancer	0.000161	0.000189	CcSEcCtD
Baclofen—GABBR1—GPCR downstream signaling—ANXA1—kidney cancer	0.000159	0.00446	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—ITPR2—kidney cancer	0.000158	0.00443	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—SFRP2—kidney cancer	0.000149	0.00417	CbGpPWpGaD
Baclofen—GABBR1—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000147	0.00411	CbGpPWpGaD
Baclofen—Asthenia—Doxorubicin—kidney cancer	0.000146	0.000172	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—ANXA1—kidney cancer	0.000145	0.00405	CbGpPWpGaD
Baclofen—Pruritus—Doxorubicin—kidney cancer	0.000144	0.000169	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—CTNNA1—kidney cancer	0.000144	0.00402	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—EIF4EBP1—kidney cancer	0.000143	0.00399	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—HSPB1—kidney cancer	0.000143	0.00399	CbGpPWpGaD
Baclofen—Diarrhoea—Doxorubicin—kidney cancer	0.000139	0.000164	CcSEcCtD
Baclofen—GABBR1—GPCR ligand binding—POMC—kidney cancer	0.000138	0.00387	CbGpPWpGaD
Baclofen—Dizziness—Doxorubicin—kidney cancer	0.000135	0.000158	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—ANXA1—kidney cancer	0.000133	0.00371	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—TSC1—kidney cancer	0.000133	0.00371	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PSMD7—kidney cancer	0.000133	0.00371	CbGpPWpGaD
Baclofen—Vomiting—Doxorubicin—kidney cancer	0.000129	0.000152	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—FLT1—kidney cancer	0.000129	0.0036	CbGpPWpGaD
Baclofen—Rash—Doxorubicin—kidney cancer	0.000128	0.000151	CcSEcCtD
Baclofen—Dermatitis—Doxorubicin—kidney cancer	0.000128	0.000151	CcSEcCtD
Baclofen—Headache—Doxorubicin—kidney cancer	0.000127	0.00015	CcSEcCtD
Baclofen—GABBR2—GPCR downstream signaling—POMC—kidney cancer	0.000121	0.00339	CbGpPWpGaD
Baclofen—Nausea—Doxorubicin—kidney cancer	0.000121	0.000142	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—CASP2—kidney cancer	0.00012	0.00336	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—AKAP13—kidney cancer	0.00012	0.00336	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PAK1—kidney cancer	0.000119	0.00333	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—JUNB—kidney cancer	0.000119	0.00333	CbGpPWpGaD
Baclofen—GABBR1—Neuronal System—MAPK1—kidney cancer	0.000113	0.00315	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—POMC—kidney cancer	0.00011	0.00308	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—GRB7—kidney cancer	0.00011	0.00307	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—ITPR2—kidney cancer	0.000102	0.00285	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—IGF2—kidney cancer	9.74e-05	0.00272	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CDKN2B—kidney cancer	9.7e-05	0.00271	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—IGF1R—kidney cancer	9.42e-05	0.00263	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—SLC5A5—kidney cancer	9.39e-05	0.00263	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CTNNA1—kidney cancer	9.25e-05	0.00259	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—EIF4EBP1—kidney cancer	9.2e-05	0.00257	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—HSPB1—kidney cancer	9.2e-05	0.00257	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—RAF1—kidney cancer	9.08e-05	0.00254	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—SLC2A1—kidney cancer	9.07e-05	0.00254	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—IL2—kidney cancer	8.96e-05	0.00251	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PSMD7—kidney cancer	8.55e-05	0.00239	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—ANXA1—kidney cancer	8.55e-05	0.00239	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—TSC1—kidney cancer	8.55e-05	0.00239	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—FLT1—kidney cancer	8.28e-05	0.00232	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—IL2—kidney cancer	8.14e-05	0.00228	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—POMC—kidney cancer	7.81e-05	0.00218	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—HIF1A—kidney cancer	7.75e-05	0.00217	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—TSC2—kidney cancer	7.74e-05	0.00216	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—JUNB—kidney cancer	7.68e-05	0.00215	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PAK1—kidney cancer	7.68e-05	0.00215	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—KDR—kidney cancer	7.42e-05	0.00207	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—ABCB1—kidney cancer	7.16e-05	0.002	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—POMC—kidney cancer	7.09e-05	0.00198	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—APC—kidney cancer	6.83e-05	0.00191	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—KIT—kidney cancer	6.83e-05	0.00191	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—MAPK3—kidney cancer	6.54e-05	0.00183	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—POMC—kidney cancer	6.5e-05	0.00182	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—BRAF—kidney cancer	6.42e-05	0.0018	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—IGF2—kidney cancer	6.28e-05	0.00176	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CDKN2B—kidney cancer	6.25e-05	0.00175	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—MAPK1—kidney cancer	6.23e-05	0.00174	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—IGF1R—kidney cancer	6.07e-05	0.0017	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—PIK3CA—kidney cancer	5.95e-05	0.00166	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—KRAS—kidney cancer	5.88e-05	0.00164	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—RAF1—kidney cancer	5.85e-05	0.00164	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—IL2—kidney cancer	5.77e-05	0.00162	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—PIK3CA—kidney cancer	5.4e-05	0.00151	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—RAF1—kidney cancer	5.36e-05	0.0015	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—RELA—kidney cancer	5.34e-05	0.00149	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—ERBB2—kidney cancer	5.3e-05	0.00148	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—IL2—kidney cancer	5.24e-05	0.00147	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—MTOR—kidney cancer	5.23e-05	0.00146	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—HIF1A—kidney cancer	5e-05	0.0014	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—TSC2—kidney cancer	4.98e-05	0.00139	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CDKN1B—kidney cancer	4.91e-05	0.00137	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—IL2—kidney cancer	4.81e-05	0.00134	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—KDR—kidney cancer	4.78e-05	0.00134	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CCND1—kidney cancer	4.69e-05	0.00131	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—JUN—kidney cancer	4.68e-05	0.00131	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CTNNB1—kidney cancer	4.64e-05	0.0013	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PTEN—kidney cancer	4.52e-05	0.00127	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—APC—kidney cancer	4.4e-05	0.00123	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—KIT—kidney cancer	4.4e-05	0.00123	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—MAPK3—kidney cancer	4.22e-05	0.00118	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—POMC—kidney cancer	4.19e-05	0.00117	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—BRAF—kidney cancer	4.14e-05	0.00116	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—VEGFA—kidney cancer	4.09e-05	0.00114	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—RAF1—kidney cancer	4.05e-05	0.00113	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—MAPK1—kidney cancer	4.01e-05	0.00112	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—MAPK3—kidney cancer	3.86e-05	0.00108	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—PIK3CA—kidney cancer	3.83e-05	0.00107	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—KRAS—kidney cancer	3.79e-05	0.00106	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—MYC—kidney cancer	3.76e-05	0.00105	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—MAPK1—kidney cancer	3.68e-05	0.00103	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—PIK3CA—kidney cancer	3.48e-05	0.000974	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—KRAS—kidney cancer	3.47e-05	0.000971	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—RAF1—kidney cancer	3.45e-05	0.000966	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—RELA—kidney cancer	3.44e-05	0.000962	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—ERBB2—kidney cancer	3.42e-05	0.000956	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—MTOR—kidney cancer	3.37e-05	0.000943	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PIK3CA—kidney cancer	3.19e-05	0.000893	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CDKN1B—kidney cancer	3.17e-05	0.000885	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—IL2—kidney cancer	3.1e-05	0.000866	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—TP53—kidney cancer	3.09e-05	0.000863	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CCND1—kidney cancer	3.02e-05	0.000845	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—JUN—kidney cancer	3.01e-05	0.000843	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CTNNB1—kidney cancer	2.99e-05	0.000836	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PTEN—kidney cancer	2.91e-05	0.000815	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—VEGFA—kidney cancer	2.63e-05	0.000736	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—MAPK3—kidney cancer	2.49e-05	0.000697	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—MYC—kidney cancer	2.42e-05	0.000678	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—MAPK1—kidney cancer	2.37e-05	0.000663	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—KRAS—kidney cancer	2.24e-05	0.000626	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PIK3CA—kidney cancer	2.06e-05	0.000575	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—TP53—kidney cancer	1.99e-05	0.000556	CbGpPWpGaD
